| SCHOLAR ROCK HLDG DL-,001 |
| USA |
| Gesundheit |
| US80706P1030 / A2JMQW |
| 2QK (Frankfurt) / SRRK (NASDAQ) |
| FRA:2QK, ETR:2QK, 2QK:GR, NASDAQ:SRRK |
| - |
| https://scholarrock.com/ |
|
Scholar Rock Holding Corporation Common Stock represents an equity interest in Scholar Rock Holding Corporation, a biopharmaceutical company focused on discovering, developing, and delivering medicines for serious diseases, with an emphasis on rare n..
>Volltext.. |
| 5802.82 Mio. EUR |
| 5554.59 Mio. EUR |
| - |
| -348.67 Mio. EUR |
| -351.86 Mio. EUR |
| -2.97 EUR |
| 175.53 Mio. EUR |
| 376.41 Mio. EUR |
| -255.62 Mio. EUR |
| 6.81 |
| - |
| -29.43% |
| - |
| - |
| - |
| - |
| SCHOLAR ROCK |
| 10.09.26 |
|